1h Free Analyst Time
The clinical trials market in US is forecasted to grow by USD 5.9 billion during 2022-2027, accelerating at a CAGR of 5.3% during the forecast period. The report on the clinical trials market in US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by a rise in a number of clinical trials of drugs, the rise in the adoption of artificial intelligence (AI)-based tools for drug delivery, and the growing demand for personalized medicine and targeted therapies.
The clinical trials market in US is segmented as below:
By Type
- Phase III
- Phase I
- Phase II
- Phase IV
By Service Type
- Interventional studies
- Observational studies
- Expanded access studies
By Indication
- Oncology
- CNS
- Autoimmune/Inflammation
- Cardiovascular and others
The report on the clinical trials market in US covers the following areas:
- Clinical trials market in US sizing
- Clinical trials market in US forecast
- Clinical trials market in US industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by Service Type
8 Market Segmentation by Indication
9 Customer Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the clinical trials market in US: Medpace Holdings Inc., Laboratory Corp. of America Holdings, Sanofi, CTI Clinical Trial and Consulting Inc., ICON plc, Syneos Health Inc., IQVIA Holdings Inc., Charles River Laboratories International Inc., Parexel International Corp., Pfizer Inc., Thermo Fisher Scientific Inc., Caidya, Accell Clinical Research LLC, Clinipace Inc., eResearchTechnology GmbH, Apex Medical Research Inc., WuXi AppTec Co. Ltd., Novartis AG, Novo Nordisk AS, and Eli Lilly and Co..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is advancement in technology and scientific research."
According to the report, one of the major drivers for this market is the rise in number of clinical trials of drugs.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Accell Clinical Research LLC
- Apex Medical Research Inc.
- Caidya
- Charles River Laboratories International Inc.
- Clinipace Inc.
- CTI Clinical Trial and Consulting Inc.
- Eli Lilly and Co.
- eResearchTechnology GmbH
- ICON plc
- IQVIA Holdings Inc.
- Laboratory Corp. of America Holdings
- Medpace Holdings Inc.
- Novartis AG
- Novo Nordisk AS
- Parexel International Corp.
- Pfizer Inc.
- Sanofi SA
- Syneos Health Inc.
- Thermo Fisher Scientific Inc.
- WuXi AppTec Co. Ltd.
